Prostate-apoptosis response-4 phosphorylation in vascular smooth muscle

Arch Biochem Biophys. 2013 Jul 1;535(1):84-90. doi: 10.1016/j.abb.2012.11.009. Epub 2012 Dec 3.

Abstract

The protein prostate-apoptosis response (Par)-4 has been implicated in the regulation of smooth muscle contraction, based largely on studies with the A7r5 cell line. A mechanism has been proposed whereby Par-4 binding to MYPT1 (the myosin-targeting subunit of myosin light chain phosphatase, MLCP) blocks access of zipper-interacting protein kinase (ZIPK) to Thr697 and Thr855 of MYPT1, whose phosphorylation is associated with MLCP inhibition. Phosphorylation of Par-4 at Thr155 disrupts its interaction with MYPT1, exposing the sites of phosphorylation in MYPT1 and leading to MLCP inhibition and contraction. We tested this "padlock" hypothesis in a well-characterized vascular smooth muscle system, the rat caudal artery. Par-4 was retained in Triton-skinned tissue, suggesting a tight association with the contractile machinery, and indeed Par-4 co-immunoprecipitated with MYPT1. Treatment of Triton-skinned tissue with the phosphatase inhibitor microcystin (MC) evoked phosphorylation of Par-4 at Thr155, but did not induce its dissociation from the contractile machinery. Furthermore, analysis of the time courses of MC-induced phosphorylation of MYPT1 and Par-4 revealed that MYPT1 phosphorylation at Thr697 or Thr855 preceded Par-4 phosphorylation. Par-4 phosphorylation was inhibited by the non-selective kinase inhibitor staurosporine, but not by inhibitors of ZIPK, Rho-associated kinase or protein kinase C. In addition, Par-4 phosphorylation did not occur upon addition of constitutively-active ZIPK to skinned tissue. We conclude that phosphorylation of Par-4 does not regulate contraction of this vascular smooth muscle tissue by inducing dissociation of Par-4 from MYPT1 to allow phosphorylation of MYPT1 and inhibition of MLCP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amides / pharmacology
  • Animals
  • Apoptosis Regulatory Proteins / antagonists & inhibitors
  • Apoptosis Regulatory Proteins / metabolism*
  • Arteries / drug effects
  • Arteries / metabolism
  • Blotting, Western
  • Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Death-Associated Protein Kinases
  • Immunoprecipitation
  • Indoles / pharmacology
  • Male
  • Maleimides / pharmacology
  • Microcystins / pharmacology
  • Muscle Contraction
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism*
  • Octoxynol / metabolism
  • Phosphorylation
  • Protein Binding
  • Protein Phosphatase 1 / genetics
  • Protein Phosphatase 1 / metabolism*
  • Pyridines / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Proteins / pharmacology
  • Staurosporine / pharmacology
  • Threonine / metabolism
  • Time Factors
  • rho-Associated Kinases / antagonists & inhibitors

Substances

  • Amides
  • Apoptosis Regulatory Proteins
  • Indoles
  • Maleimides
  • Microcystins
  • Pyridines
  • Recombinant Proteins
  • prostate apoptosis response-4 protein
  • Y 27632
  • Threonine
  • microcystin
  • Octoxynol
  • Death-Associated Protein Kinases
  • rho-Associated Kinases
  • Cyclic AMP-Dependent Protein Kinases
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Ppp1r12a protein, rat
  • Protein Phosphatase 1
  • Staurosporine
  • bisindolylmaleimide I